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Abstract
Context: The current study aimed at providing an evidence - based and up-to-date review of the literature regarding the assessment
and outcomes of pregnancy in patients with renal transplant.
Design: It was a review of the current literature.
Conclusions: According to the current study findings, the function or survival of renal allograft was not adversely affected by
getting pregnant. Therefore, ideal care for these patients needs a multidisciplinary approach including maternal-fetal medicine,
nephrology, and neonatology specialists.
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1. Introduction
Although pregnancy in females with renal disease is
increasingly observed, pregnancy in females undergoing
dialysis is rare, and maternal and fetal morbidity and mor-
tality are high under such circumstances (1, 2). Method of
choice to treat the end - stage kidney disease and improve
survival and quality of life in pregnant females with such
complications is kidney transplantation (2). Restoration
of pituitary - ovarian function and fertility in females is
another benefit of this method (3); hence, it increases fe-
males’ chance of becoming pregnant by approximately 4
- fold compared with dialysis (4-6). Murry et al., described
the first cases of pregnancy in females with allograft kid-
ney transplantation (7). According to the reported data, it
is safe to get the conception 1 year after kidney transplan-
tation (6-8). Since the function of allograft kidney, time be-
tween kidney transplantation and pregnancy, prescribed
immunosuppression medication, and comorbid disease
make such pregnancies risky (9), preconception counsel-
ing is needed to provide safety concerns for the mother, the
infant, and the transplanted kidney.
Two major issues that arise in the first place by patients
are: 1) The impact of pregnancy on transplanted kidney
and 2) The outcome of pregnancy notwithstanding renal
transplantation and medication intake.
2. Methods
The English scientific databases including Web of Sci-
ence, PubMed, and Google Scholar as well as Persian
databases such as SID, Magiran, and Iranmedex were
searched from 1900 to 2015. The keywords searched in
the current study were: [(kidney or renal) and transpar-
ent] and [pregnancy]. All papers regarding the outcomes
of pregnancy patients with renal transplantation were en-
rolled.
3. Results
3.1. The Effect of Pregnancy on Transplanted Kidney
Although graft dysfunction and obstructive uropathy
are reported in pregnant patients with kidney transplan-
tation (9), studies compared the long - term outcomes of
pregnancy on transplanted kidney with nulliparous trans-
planted controls did not show significant differences in
the function or survival of graft in long term (10-17) (Table
1). Graft function in the 10 - year period was similar be-
tween patients with pregnancy history and controls (12-15).
No significant differences are reported in the mean level
of creatinine in pre- and post - pregnancy period, in many
studies (12, 18-20). Rosha et al., reported no differences be-
tween the median of estimated glomerular filtration rate
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(eGFR) before pregnancy and that of the time of follow - up
at the last postpartum visits (17).
Serum creatinine before pregnancy could be a prog-
nostic factor in the decline of kidney function with preg-
nancy as the patients with pre-pregnancy serum creatinine
level≥ 1.7 mg/dL had significant decline in renal function
more often than the ones with normal baseline creatinine
(20). As stated in the European best practice guidelines for
renal transplantation, survival and graft function of such
pregnant females, in the presence of normal graft function
before pregnancy, is not worse (21).
Table 1. Graft Survival
Author Long - termGraft Survival Acute
Rejection %
Al Duraihimh et al. (19) Graft loss within 2 years of
delivery: 0
2.9
Kashanizadeh et al. (11) 91%, at 5 - year similar to the
controls
Gorgulu et al. (12) Similar to the controls at 10
years
Gutierrez et al. (13) Similar to the controls at 10
years
0.0
Kim et al. (14) Similar to control group, 78.5%
at 10th year, 67.3% at 15th year
Pour - Reza - Gholi et al.
(15)
Control group, 94.5% at 5 years
and 77.1% at 10 years
6.7
Rahamimov et al. (10) 77.6% at 10 years, 61.6% at 15
years
0.0
Bouattar et al. (18) Graft loss within 59 months: 0 0.0
Yassaee andMoshiri
(22)
Graft loss over 2 years: 3.2% 2.1
Framarino et al. (23) 1.6
Pezeshki et al. (24) 11.0
Coscia et al. (NTPR) (25) Graft loss within 2 years of
delivery: 8% - 11%
Sibanda et al. (26) Graft loss rate during 2 years of
delivery: 6%
Ghanem et al. (9) 0.0
Di Loreto et al. (27) Graft loss at 2 years: 0 0.0
Bramhamet al. (28) 2.0
Yildirim andUslu (29) Graft loss within 6 months of
delivery: 0
0.0
3.2. Fetal and Maternal Outcomes
Two important factors affecting the pregnancy out-
comes are the serum creatinine level prior to pregnancy
and the interval between transplantation and pregnancy.
Therefore, significant associations are reported between
increased risk in cesarean section rate and short inter-
val between pregnancy and allograft transplantation (< 2
years) as well as preterm delivery and high serum creati-
nine level (> 1.5 mg/dL) before pregnancy (29).
The overall live birth rate after kidney transplantation
in the US is reported higher than that of general popula-
tion: 73.5% (95% CI: 72.1 - 74.9) versus 66.7% in a meta - anal-
ysis conducted on 3570 kidney transplant recipients (4). In
other studies, live birth rate is reported 43.2% to 91% (Table
2).
The increased miscarriage rate after kidney transplan-
tation is 14.0% and the rate of some adverse outcomes
such as preeclampsia, preterm delivery, and delivery by ce-
sarean section is more than that of normal population in
such patients (4, 13, 24, 25).
Gestational diabetes, anemia, infection, graft dysfunc-
tion, graft pyelonephritis, de novo proteinuria > 1 g/d,
and obstructive uropathy are other complications affect-
ing such pregnancies (9, 17).
It is argued that the sole independent factor to pre-
vent severe complications is the high glomerular filtration
rate (GFR) before getting pregnant (2). Accordingly, dias-
tolic blood pressure (BP) > 90 mmHg in the second and
third trimesters and serum creatinine level > 125µM/L are
considered potential predictive factors for poor pregnancy
outcomes (28).
4. Discussion
As already noted, successful pregnancy is expected in
the majority of females with transplanted kidney, but ma-
ternal and fetal complication rates are high.
The most common complications are pre - eclampsia,
low birth weight, and premature birth both in reports
from single centers and data from large pregnancy reg-
istries. It is argued that there are some reasons for high
prevalence of complications in such patients:
1. Continuation of the underlying diseases resulting in
kidney transplant and their effects on pregnancy out-
comes (28).
2. As mentioned above, the function of transplanted kid-
ney before pregnancy has a great impact on pregnancy
complications (2, 28, 29).
3. The immunosuppressive medications could contribute
to the high pregnancy complication rate in the kidney
transplanted cases (31, 32).
It was reported in some medications used by such pa-
tients that prednisone and cyclosporine can induce hyper-
tension during pregnancy or exacerbate it and be subse-
quently followed by an increased risk of preeclampsia and
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early delivery resulting from it (31, 32). Cyclosporine is also
associated with low birth weight (25).
In a Meta - analysis, the incidence of gestational di-
abetes mellitus (GDM) in pregnant females with kidney
transplants was 8% (4). It is assumed that diabetogenic ef-
fect of immunosuppressive drugs, especially prednisolone
and tacrolimus that are used more frequently in patients
with kidney transplantation, is the cause of increased inci-
dence of GDM (2, 28).
Cardiovascular disease along with diabetes is the com-
mon comorbidity in kidney transplant recipients and both
could cause a high risk pregnancy in such patients and put
their allograft at risk too. Furthermore, there are some
other special factors including advanced maternal age,
long - term exposure to high risk pharmacological medi-
cations, and previous abdominal surgery that increase the
complications of their pregnancy (4).
It is observed that in high risk population the risk of
preeclampsia could be reduced by taking aspirin (33). Ac-
cording to the current UK guidelines, it should be advised
to all pregnant females with chronic kidney disease (CKD)
to take aspirin during their pregnancy (34), despite its effi-
cacy to prevent preeclampsia, it is never studied in females
with kidney transplants.
The majority of high caesarean section rates in the ones
undergoing kidney transplantation is attributed to fetal
distress or maternal indications and many are performed
preterm.
It seems that the incidence of prematurity and low
birth weight is high in such pregnancies. Majority of fe-
males with kidney transplant have children with natural
development and could achieve their normal height and
weight; and their performance is usually appropriate in
school (35, 36).
Data on graft survival are reassuring and the range
of graft loss is 0% and 8.6% at 1 year following the preg-
nancy (37), but the important concern is high incidence of
pregnancy complications in pregnant females with kidney
transplant. Investigators consistently showed that preg-
nancy after renal transplantation generally has excellent
graft survival. In 5 studies, long-term outcomes were com-
pared between patients with kidney transplantation and a
history of pregnancy and those of nulliparous as the con-
trol and no significant differences were observed in the
graft function or survival (10-14). The reported survival
rates were 61.6% to 84.8% in patients with a history of preg-
nancy versus 58.1% to 78.8% in the controls at the 15 - year
follow-up (10, 14).
5. Conclusions
According to the current study findings, the function
or survival of renal allograft was not adversely affected by
pregnancy. Despite the fact that restoration of fertility af-
ter transplantation may alter the quality of life, obstetric
and perinatal complications are increased in this popula-
tion. It should be considered in consultation with these
patients and decision making process and post - transplan-
tation pregnancies should be managed in a tertiary cen-
ter. Therefore, ideal care for these patients needs a multi-
disciplinary approach including maternal - fetal medicine,
nephrology, and neonatology specialists.
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